SCHEMBL6474489

SCHEMBL6474489

N#Cc1ccc(C(Cc2ccc(C(F)(F)F)cc2)Cc2nc[nH]n2)cc1

nearest known ligand 0.44

Predicted protein targets (top 18)

geneUniProtsupporting neighboursconfidence
CYP19A1 P11511 3/20 0.44
KIF11 P52732 1/20 0.41
VNN1 O95497 3/20 0.41
TRPM8 Q7Z2W7 1/20 0.36
PTGDR2 Q9Y5Y4 1/20 0.35
KDM1A O60341 1/20 0.35
MAOB P27338 1/20 0.35
CYP3A4 P08684 1/20 0.34
CYP3A5 P20815 1/20 0.34
RPS6KB1 P23443 1/20 0.33
DGAT1 O75907 1/20 0.33
SOAT1 P35610 1/20 0.33
KCNH2 Q12809 1/20 0.33
DAO P14920 1/20 0.33
RORC P51449 2/20 0.32
ESR1 P03372 1/20 0.32
ESR2 Q92731 1/20 0.32
SMO Q99835 1/20 0.32

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6526163 0.90 CYP19A1 (0.41) CYP19A1MAOBESR1ESR2
SCHEMBL6527102 0.86 TRPA1 (0.40) CYP19A1PTGDR2KDM1AMAOBRPS6KB1
SCHEMBL6522652 0.85 CYP19A1 (0.42) CYP19A1KIF11VNN1TRPM8PTGDR2
SCHEMBL9159563 0.75 KIF11 (0.47) CYP19A1KIF11VNN1TRPM8PTGDR2
SCHEMBL30525997 0.73 ESR1 (0.52) CYP19A1CYP3A4KCNH2ESR1ESR2
SCHEMBL5925447 0.70 CYP19A1 (0.51) CYP19A1KIF11CYP3A4
SCHEMBL690958 0.69 HRH3 (0.54) CYP19A1MAOB
SCHEMBL28224476 0.69 IDO1 (0.43) MAOB
SCHEMBL19877208 0.68 KCNJ1 (0.42) CYP19A1MAOBKCNH2DAO
Hydrochloric Acid SCHEMBL690028 0.68 HRH3 (0.53) CYP19A1MAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1534265-A1 COMBINATION OF AN AROMATASE INHIBITOR WITH A BISPHOSPHONATE Novartis AG (CH) 2005-06-01 EP disclosed
WO-2004012728-A1 COMBINATION OF AN AROMATASE INHIBITOR WITH A BISPHOSPHONATE NOVARTIS AG (CH) 2004-02-12 WO disclosed